about
TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cellsA high susceptibility to redox imbalance of the transmissible stages of Plasmodium falciparum revealed with a luciferase-based mature gametocyte assayNonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice.Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cellsOptimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vectorHIV-1 Tat-based vaccines: from basic science to clinical trials.Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulationDevelopment of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compoundsVirological consequences of early events following cell-cell contact between human immunodeficiency virus type 1-infected and uninfected CD4+ cells.Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patientsDevelopment and use of SIV-based Integrase defective lentiviral vector for immunization.Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.Multicolor bioluminescence boosts malaria research: quantitative dual-color assay and single-cell imaging in Plasmodium falciparum parasitesLentivirus-based virus-like particles as a new protein delivery tool.Human immunodeficiency virus type 1 (HIV-1) protease inhibitors block cell-to-cell HIV-1 endocytosis in dendritic cells.DC contact with HIV-1-infected cells leads to high levels of Env-mediated virion endocytosis coupled with enhanced HIV-1 Ag presentation.Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.Persistence of azacytidine-induced SCEs and genomic methylation in CHO cells in vitro.Retinoids as modulators of metabolism: their inhibitory effect on cyclophosphamide and 7,12-dimethylbenz[a]anthracene induced sister chromatid exchanges in a metabolically competent cell line.Murine granulocyte-macrophage colony-stimulating factor expressed from a bicistronic simian immunodeficiency virus-based integrase-defective lentiviral vector does not enhance T-cell responses in mice.Erratum to: Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.T cell receptor excision circles (TRECs) analysis during acute intrarectal infection of cynomolgus monkeys with pathogenic chimeric simian human immunodeficiency virus.Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA.Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant.Antimutagenic activities of naturally occurring polyamines in Chinese hamster ovary cells in vitro.Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay.Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cellsSuccessful Immunization with a Single Injection of Non-integrating Lentiviral VectorFull expression of transfected nonproducer interfering HIV-1 proviral DNAabrogates susceptibility of human He-La CD4+ cells to HIVAntimutagenic activities of naturally occuring polyamines in CHO cells
P50
Q28119089-8F00F223-3CCB-4917-8992-821D7AED4B82Q30044470-B2D534FC-00D6-49B1-8EDC-C27F4B6F1849Q33865077-EE30BAAE-3BB0-4E01-A26C-C6556A32CF14Q34085930-60727CFE-76C9-451B-B341-EB03525C9E39Q34166320-07D9AE80-3953-491D-88B5-2AAE1EA02F59Q34978901-6FA51347-F511-42D8-B537-E019E5EAF3D8Q35041156-79ADAA41-1A9C-431C-A602-B345697911D9Q35091567-52664A31-51ED-4294-A043-22EBBC1B879FQ36845702-C9A83FDF-FBBB-4604-89B0-E8F55BA2C056Q37204137-280479B4-8FF6-482F-82AE-B9BD9FB87C91Q37369322-B6E05844-7E0F-48C3-B895-FB927B27FF5EQ37857291-D8C38338-F9B9-4C1A-A030-0527A51B751EQ38968045-99CAC3E8-7EF8-4D29-9E45-3694EDBE480CQ39728578-04311DE0-61D6-4F0F-ACFF-C79121554B90Q39822076-CB634568-A690-416E-A100-99224376B383Q39889498-04FCFFED-EF4A-49EF-A412-5E55CA00AF01Q40187494-D627A0C9-E85D-42CB-8EC2-D26B5E59CE03Q41717338-560B77E7-2DD7-4BA0-B3CE-0446183A0127Q41729602-E45C49D0-A3FB-4AC4-88D6-519A125F6D26Q42182905-4F4C43F5-6C84-42FC-A6C9-C5A84C45E912Q42582704-71AF5014-2A90-4AAB-8553-3786E6A9484FQ44499582-4275E206-9F16-4B7B-B721-34D573D68019Q45406572-A74BDC3C-624F-4F6E-BC2D-54E6146DDF8EQ45625159-94C2BE58-AE1F-4CC5-9F4E-A7E2B6B2850FQ45884890-E8761835-A191-46C9-8C0D-0391279F4BEFQ46581927-159DD077-6AC6-404A-9E50-CBF76DB388EBQ51998598-82FFA3CD-30FE-4601-83A1-00FC989D06F1Q54667196-9F655003-976F-483D-B02F-9288C5C7C9CFQ57616754-56958256-148E-410A-8CD1-A35A364BE659Q59257212-94EBCB46-559F-4AFD-9D46-D8F0790F4090Q59257306-31195566-19CF-4C53-8F3B-02EF321898B3Q59257327-BC52AD33-EE58-4939-93FE-76459947421D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberta Bona
@ast
Roberta Bona
@en
Roberta Bona
@es
Roberta Bona
@nl
Roberta Bona
@sl
type
label
Roberta Bona
@ast
Roberta Bona
@en
Roberta Bona
@es
Roberta Bona
@nl
Roberta Bona
@sl
prefLabel
Roberta Bona
@ast
Roberta Bona
@en
Roberta Bona
@es
Roberta Bona
@nl
Roberta Bona
@sl
P1053
O-1730-2017
P106
P21
P31
P3829
P496
0000-0002-9226-3734